The Minnesota Senate has approved an omnibus marijuana bill that would make a wide range of changes to the state’s legal marijuana system, including new licensing rules, updated local control provisions, expanded labeling requirements and a new process tied to psilocybin policy.

Senate File 4401, sponsored by State Senator David Dibble (D) and State Senator Lindsey Port (D), was passed by the full Senate on May 12 after being amended on the floor.

The measure would update Minnesota’s marijuana law as the state continues preparing for the full rollout of its adult-use market, which was legalized in 2023.

Among its key provisions, the bill would allow local governments to limit the number of registered marijuana retailers, but not below one retailer for every 12,500 residents. Local jurisdictions could allow more retailers, but they would also be required to verify zoning, fire code and building code compliance before businesses are approved to operate.

The proposal would also require local governments to conduct at least one unannounced annual age-verification compliance check for each registered marijuana or hemp retailer.

A major portion of SF 4401 focuses on licensing. The bill would create a cannabis macrobusiness license, allowing certain operators to engage in multiple parts of the industry under one license type, while also restructuring the state’s use of endorsements for cultivation, manufacturing, retail, transport and medical marijuana-related activities.

The bill would also block licenses for individuals or businesses convicted of illegally selling marijuana after August 1, 2023, unless five years have passed. Similar restrictions would apply to certain violations of state marijuana law, with exceptions for good-faith mistakes that did not involve gross negligence, illegal sales or harm to the public.

SF 4401 would make several changes to product labeling, especially for lower-potency hemp edibles, while requiring more consumer-facing information and allowing some required details to be provided through scannable codes. It would also classify data reported to the Office of Cannabis Management through the statewide monitoring system as nonpublic.

The measure also includes a psilocybin-related provision requiring the Office of Cannabis Management to review federal funding opportunities that could support a state psilocybin therapeutic use program for adults 21 and older with qualifying medical conditions.

With Senate approval secured, the bill now moves to the House for consideration.